Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Threshold is £37 000 per QALY
| The first 150 words of the full text of this article appear below. |
EDITOR
Although I agree with most of Law's and Wald's conclusions
with regard to risk factors, I cannot agree that, as a result, treatment thresholds do not exist.1 With regard to the
risk of coronary heart disease, the recent joint British
recommendations recommend starting treatment of high blood pressure at
an absolute 10 year risk of coronary heart disease of 15%, and of a
high lipid ratio at 30%.2 Neither these recommendations
nor those of the Standing Medical Advisory Committee explain why these
particular thresholds have been set. (Neither do they mention when
treatment should be stopped.) But could or should it have something to
do with cost? I think that, despite the article's title, Law and Wald
acknowledge this implicitly by saying that people at high risk should
be targeted.
There have been several published cost effectiveness analyses of
lipid lowering drugs. The report from Pickin et al puts
Read all Rapid Responses